PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Skyrizi 360mg/2.4ml solution for injection cartridges
0105030C0BBAAAA
Skyrizi Risankizumab Gastro-Intestinal System No data available
Skyrizi 75mg/0.83ml inj pre-filled syringes
1305030I0BBAAAA
Skyrizi Risankizumab Skin No data available
Sleepeaze 25mg tablets
0304010N0BHADAG
Boots (Diphenhydramine hydrochloride) Diphenhydramine hydrochloride Respiratory System No data available
Sleepeaze 50mg tablets
0304010N0BHACAP
Boots (Diphenhydramine hydrochloride) Diphenhydramine hydrochloride Respiratory System No data available
Slinky bandage 5cm x 4m
20020200481
Slinky bandage 5cm x 4m Arm Sling/Bandages Dressings No data available
SLO Drink 3 oral powder
190700000BBCHA0
Proprietary compound preparation BNF 1907000 Other base/diluent/suspending agent/stabiliser preparations Other Drugs and Preparations No data available
SLO Drink Stage 1:IDDSI 2 Mildly Thick oral pdr (2 flavours)
0913421B0BBAAAA
SLO powder pre-thickened drink Powder pre-thickened drink (0913421) Nutrition and Blood No data available
SLO Drink Stage 2:IDDSI 3 Moder Thick oral pdr (2 flavours)
0913421B0BBABAB
SLO powder pre-thickened drink Powder pre-thickened drink (0913421) Nutrition and Blood No data available
SLO Milkshake+ IDDSI 4 Extremely Thick pdr 50g sach banana
0913671A0BBAAAA
SLO powder 2.7 kcal/ml milkshake pre-thickened Powder 2.7 kcal/ml milkshake pre-thickened (0913671) Nutrition and Blood No data available
SLO Milkshake+ IDDSI 4 Extremely Thick pdr 50g sach s/berry
0913671A0BBACAA
SLO powder 2.7 kcal/ml milkshake pre-thickened Powder 2.7 kcal/ml milkshake pre-thickened (0913671) Nutrition and Blood No data available
SLO Syrup Cold IDDSI 1, 2 and 3 liquid thickener conc liq
0913411C0BBAAAA
SLO Syrup liquid thickener concentrate liquid Liquid disc or non ACBS thickener - gum based (0913411) Nutrition and Blood No data available
SLO Syrup Hot IDDSI 1, 2 and 3 liquid thickener conc liq
0913411C0BBADAA
SLO Syrup liquid thickener concentrate liquid Liquid disc or non ACBS thickener - gum based (0913411) Nutrition and Blood No data available
Slo-Indo 75mg capsules
1001010K0BLAAAD
Slo-Indo Indometacin Musculoskeletal and Joint Diseases No data available
Slo-Pro 160mg capsules
0204000R0BUAAAB
Slo-Pro Propranolol hydrochloride Cardiovascular System No data available
Slofedipine 20mg tablets
0206020R0BVAAAR
Slofedipine Nifedipine Cardiovascular System No data available
Slofedipine XL 30mg tablets
0206020R0BVABAN
Slofedipine Nifedipine Cardiovascular System No data available
Slofedipine XL 60 tablets
0206020R0BVACAP
Slofedipine Nifedipine Cardiovascular System No data available
Slofenac 75mg SR tablets
1001010C0BWAAAL
Slofenac Diclofenac sodium Musculoskeletal and Joint Diseases No data available
Slomon XL 60 tablets
0206010K0CFAAAE
Slomon Isosorbide mononitrate Cardiovascular System No data available
Slow Fe Folic 160mg/400microgram tablets
0901011Q0BLAAAL
Slow-Fe Folic Iron and folic acid Nutrition and Blood No data available
Slow-Fe 160mg tablets
0901011P0BEAAAL
Slow-Fe Ferrous sulfate Nutrition and Blood No data available
Slow-Mag 535mg gastro-resistant tablets
090501300BBFVA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Slow-Mag 535mg/110mg gastro-resistant tablets
090501300BBFUA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Slow-Trasicor 160mg tablets
0204000N0BEAAAF
Slow-Trasicor Oxprenolol hydrochloride Cardiovascular System No data available
SMA Gold Prem 2 Catch-up Formula powder
0913381A0BBAAAA
SMA powder disc cond specific complete infant formula Pdr disc condition specific complete infant formula(0913381) Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.